Literature DB >> 8865319

Nitric oxide (NO)-releasing pathway of FK409 in the presence of sulfhydryl-bearing compounds.

S Fukuyama1, T Azuma, Y Hirasawa, N Morokoshi, T Akama, S Koda, Y Kita.   

Abstract

PURPOSE: We have recently reported that degradation of FK409 with generation of NO is spontaneous and is accelerated in the presence of sulfhydryl-bearing compounds, such as L-cysteine (Cys) and glutathione (GSH). The purpose of the present study is to investigate the NO-releasing pathway of FK409 in the presence of sulfhydryl-bearing compounds.
METHODS: The degradation process of FK409 in the presence of Cys or GSH was investigated by means of 1H-nuclear magnetic resonance (NMR) spectroscopy and high-performance liquid chromatography (HPLC).
RESULTS: The degradation of FK409 in the presence of Cys was dependent on concentration of Cys, and showed pH-dependency, accelerating with an increase in pH. The 1H-NMR spectra of FK409 with Cys suggested that time-dependent elimination of the hydrogen atom at the alpha-position of the nitro moiety (5-position) was accelerated by Cys in weakly alkaline solution. Cys and GSH were transformed readily, concomitant with FK409 degradation, to give their oxidized forms and probably S-nitrosothiols.
CONCLUSION: The effect of sulfhydryl-bearing compounds on FK409 degradation is due to the acceleration of deprotonation of the hydrogen atom at the 5-position by thiolate anion as well as hydroxyl ion. Sulfhydryl-bearing compounds reacted with the released NO resulting in formation of disulfides via intermediate S-nitrosothiols.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8865319     DOI: 10.1023/a:1016076623060

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens.

Authors:  K Schultz; K Schultz; G Schultz
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

2.  Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.

Authors:  L J Ignarro; H Lippton; J C Edwards; W H Baricos; A L Hyman; P J Kadowitz; C A Gruetter
Journal:  J Pharmacol Exp Ther       Date:  1981-09       Impact factor: 4.030

3.  NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.

Authors:  J F Keaney; D I Simon; J S Stamler; O Jaraki; J Scharfstein; J A Vita; J Loscalzo
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

4.  FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus. I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics.

Authors:  M Hino; M Iwami; M Okamoto; K Yoshida; H Haruta; M Okuhara; J Hosoda; M Kohsaka; H Aoki; H Imanaka
Journal:  J Antibiot (Tokyo)       Date:  1989-11       Impact factor: 2.649

5.  Close correlation between nitric oxide (NO) formation from NO releasers and the biological activities of these agents in rats.

Authors:  Y Kita; S Fukuyama; Y Hirasawa
Journal:  Jpn J Pharmacol       Date:  1995-09

6.  Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409.

Authors:  Y Kita; Y Hirasawa; K Maeda; M Nishio; K Yoshida
Journal:  Eur J Pharmacol       Date:  1994-05-12       Impact factor: 4.432

7.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.

Authors:  M Feelisch; E A Noack
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

8.  Acceleration of nitric oxide (NO) release from FK409, a spontaneous NO releaser, in the presence of sulfhydryl-bearing compounds.

Authors:  S Fukuyama; Y Hirasawa; D Cox; S Koda; Y Kita
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

9.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.

Authors:  J S Stamler; D I Simon; J A Osborne; M E Mullins; O Jaraki; T Michel; D J Singel; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

10.  A new nitric oxide (NO) releaser: spontaneous NO release from FK409.

Authors:  S Fukuyama; Y Kita; Y Hirasawa; T Azuma; A Sato; N Morokoshi; S Koda; T Yasuda; S Oka; H Sakurai
Journal:  Free Radic Res       Date:  1995-11
View more
  1 in total

1.  Decreased antipyrine clearance following endotoxin administration: in vivo evidence of the role of nitric oxide.

Authors:  K Kitaichi; L Wang; K Takagi; M Iwase; E Shibata; M Nadai; T Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.